Stockreport

Mateon’s Global Study for Artemisinin Intervention Against COVID-19 Cleared for Patient Enrollment in India

MATEON THERAPEUTICS  (MATN) 
Last mateon therapeutics earnings: 11/19 05:25 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.mateon.com
PDF AGOURA HILLS, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-ß therapeutics for oncology and COVID- [Read more]